Abstract:Machine learning (ML) systems have enabled the modelling of quantitative structure-property relationships (QSPR) and structure-activity relationships (QSAR) using existing experimental data to predict target properties for new molecules. These property predictors hold significant potential in accelerating drug discovery by guiding generative artificial intelligence (AI) agents to explore desired chemical spaces. However, they often struggle to generalize due to the limited scope of the training data. When optimized by generative agents, this limitation can result in the generation of molecules with artificially high predicted probabilities of satisfying target properties, which subsequently fail experimental validation. To address this challenge, we propose an adaptive approach that integrates active learning (AL) and iterative feedback to refine property predictors, thereby improving the outcomes of their optimization by generative AI agents. Our method leverages the Expected Predictive Information Gain (EPIG) criterion to select additional molecules for evaluation by an oracle. This process aims to provide the greatest reduction in predictive uncertainty, enabling more accurate model evaluations of subsequently generated molecules. Recognizing the impracticality of immediate wet-lab or physics-based experiments due to time and logistical constraints, we propose leveraging human experts for their cost-effectiveness and domain knowledge to effectively augment property predictors, bridging gaps in the limited training data. Empirical evaluations through both simulated and real human-in-the-loop experiments demonstrate that our approach refines property predictors to better align with oracle assessments. Additionally, we observe improved accuracy of predicted properties as well as improved drug-likeness among the top-ranking generated molecules.

Metis - A Python-Based User Interface to Collect Expert Feedback for Generative Chemistry Models

Human-in-the-loop assisted de novo molecular design

MolScore: a scoring, evaluation and benchmarking framework for generative models in de novo drug design

Generation of Rational Drug-Like Molecular Structures Through a Multiple-Objective Reinforcement Learning Framework

Guided Multi-objective Generative AI to Enhance Structure-based Drug Design

MolScore: A scoring and evaluation framework for de novo drug design

Assessing Methods and Obstacles in Chemical Space Exploration

Electron-density informed effective and reliable de novo molecular design and lead optimization with ED2Mol

Deep Molecular Dreaming: Inverse machine learning for de-novo molecular design and interpretability with surjective representations

EvoMol: a flexible and interpretable evolutionary algorithm for unbiased de novo molecular generation

MoleGear: A Java-Based Platform for Evolutionary De Novo Molecular Design

Population-based de novo molecule generation, using grammatical evolution

Bayesian molecular design with a chemical language model

Language model-guided anticipation and discovery of unknown metabolites

GuacaMol: Benchmarking Models for De Novo Molecular Design

Human-in-the-loop active learning for goal-oriented molecule generation

Scikit-Mol brings cheminformatics to Scikit-Learn

SynthFormer: Equivariant Pharmacophore-based Generation of Molecules for Ligand-Based Drug Design

MolSnapper: Conditioning Diffusion for Structure Based Drug Design

ChatMol: Interactive Molecular Discovery with Natural Language